Tewodros Eguale

Tewodros Eguale is a Professor of Epidemiology and Biostatistics in the School of Pharmacy at Massachusetts College of Pharmacy and Health Sciences (MCPHS University), where he is affiliated with the Department of Pharmaceutical Business and Administrative Sciences. His academic work bridges clinical practice, epidemiology, and health informatics, focusing on improving medication safety and effectiveness through innovative research approaches.

Dr. Eguale holds an MD, MSc in genetic epidemiology of tuberculosis, and a PhD focused on the novel use of Electronic Health Records to estimate the prevalence of off-label prescribing, its determinants, and its association with adverse drug events. His clinical background includes seven years of direct patient care experience, which informs his research in practical healthcare settings.

Dr. Eguale's research program centers on pharmacoepidemiology and pharmacoeconomics, with particular expertise in off-label prescribing practices, medication safety, and the use of electronic health records for pharmacosurveillance. His work has made significant contributions to understanding the relationship between off-label drug use and adverse drug events, and he has developed novel methods for measuring conservative prescribing practices and medication adherence. His research has directly informed priority areas identified by the WHO for incorporating active surveillance into drug monitoring systems.

His scholarly output spans multiple high-impact journals including JAMA Internal Medicine, JAMA Network Open, and the Journal of the American Medical Informatics Association. Dr. Eguale's research demonstrates consistent focus on improving medication safety through technology-enabled solutions, with recent work examining indication-based prescribing systems, clinical decision support alert optimization, and comparative effectiveness research across various therapeutic areas.

Dr. Eguale has received numerous scientific honors, including:

• 2020 Annual Scholarship Awards, Scholarship of Discovery ($1,250) from MCPHS University
• 2018 Group Award for "Towards better assessment of PharmD-Boston educational outcome through the mapping of exam questions" ($250)
• 2018 Partners in Excellence Award for work in Indication Based Prescribing
• 2013 CIHR Institute of Health Services and Policy Research Article of the Year Award ($10,000)
• Multiple awards for oral presentations at the McGill University Health Center Research Institute

As an educator, Dr. Eguale advises PhD and MSc students whose work spans pharmacoeconomics, pharmacoepidemiology, and health informatics. His graduates have gone on to successful careers in pharmaceutical industries (including Merck), consulting firms, and academic institutions. He is actively involved in multiple graduate programs at MCPHS University including Clinical Investigation and Development (MS), Clinical Research (MS), Pharmaceutical Economics and Policy (MS and PhD), and Regulatory Affairs programs.

Dr. Eguale maintains active professional affiliations with leading organizations in his field including the International Society for Pharmacoepidemiology (ISPE), the International Society for Pharmacoeconomics and Outcome Research (ISPOR), the American Medical Informatics Association (AMIA), and the American Association of Colleges of Pharmacy (AACP). These connections facilitate collaborative research and keep his work at the forefront of methodological innovation in medication safety and effectiveness research.